Burnett Zachary R, Flanigan David C
Department of Orthopaedics, The Ohio State University Wexner Medical Center, 2835 Fred Taylor Dr. Suite 2200, Columbus, OH, 43202, USA.
Curr Rev Musculoskelet Med. 2025 Mar;18(3):79-86. doi: 10.1007/s12178-024-09940-9. Epub 2024 Dec 26.
The management of horizontal cleavage meniscus tears (HCT) has evolved in recent years. Historically, HCTs have been treated with partial meniscectomy, but multiple studies have shown the long-term risks of development of arthritic changes in the knee following meniscectomy. These findings have renewed interest in meniscal preservation whenever possible, even in older patients not previously considered for meniscus repair. This article provides an overview of current management of horizontal cleavage meniscus tears and describes modern surgical techniques for repair of HCTs.
Current research studies have continued to emphasize the benefits of meniscal preservation on long-term function. Recent data has demonstrated similar success rates following repair of HCTs compared to repair of other types of meniscus tears. Additionally, multiple recent studies have demonstrated the potential benefit of biologic augmentation in decreasing failure rate after meniscal repair. Modern surgical techniques and biologic augmentation have improved outcomes of meniscal repair. However, consideration of a patient's individual goals, activity level, and expectation are important to achieve a successful outcome regardless of treatment modality. While not every patient is a candidate for meniscal repair, current data has shown it should be considered for a growing number of patients.
近年来，水平劈裂半月板撕裂（HCT）的治疗方法不断发展。从历史上看，HCT一直采用半月板部分切除术治疗，但多项研究表明，半月板切除术后膝关节发生关节炎改变的长期风险。这些发现使人们重新关注尽可能保留半月板，即使是以前未考虑进行半月板修复的老年患者。本文概述了水平劈裂半月板撕裂的当前治疗方法，并描述了修复HCT的现代手术技术。
当前的研究继续强调保留半月板对长期功能的益处。最近的数据表明，与其他类型的半月板撕裂修复相比，HCT修复后的成功率相似。此外，最近的多项研究表明，生物增强在降低半月板修复后失败率方面具有潜在益处。现代手术技术和生物增强改善了半月板修复的效果。然而，无论采用何种治疗方式，考虑患者的个人目标、活动水平和期望对于取得成功的结果都很重要。虽然并非每个患者都适合进行半月板修复，但目前的数据表明，越来越多的患者应该考虑进行半月板修复。
